Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders.

Abstract:

:The frequency of neuropsychiatric disorders is greater than that of cancer, cardiovascular disease, and diabetes combined, and is growing at a faster rate than any other ailments in the United States or Europe. Despite a considerable need for the development of treatments for central nervous system disorders, pharmaceutical companies continue to reduce investment in this area of research. Of particular concern is the treatment of diseases and disorders that affect cognitive function, which are often given a lower priority for research investment than life threatening conditions or those with overt physical symptoms. Several reasons exist for this reduced investment, including a poor understanding of the mechanisms underlying impaired cognitive function, costly and long periods of development for these medications, disproportionately lower success rates, and a stigma associated with the medical treatment of mental illness. This paper will discuss these issues, review some of the successes resulting from research investment and discuss opportunities that should encourage increased research investment in cognitive disorders and their treatment.

journal_name

Curr Pharm Des

authors

Schroeder RA,Wecker L,Philpot RM

doi

10.2174/1381612822666160127111453

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

1981-5

issue

14

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-73279

journal_volume

22

pub_type

杂志文章,评审
  • Inhibitors of HIV-1 entry.

    abstract::Since the discovery of human immunodeficiency virus (HIV) as a causative agent of acquired immune deficiency syndrome (AIDS) various strategies were employed to counter its devastating actions. One such concept relies on the prevention of HIV entry into host's "competent" cells by means of compounds known as entry inh...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319100003

    authors: Micewicz ED,Ruchala P

    更新日期:2013-01-01 00:00:00

  • CFTR inhibitors.

    abstract::The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a cAMP-regulated Cl- channel whose major function is to facilitate epithelial fluid secretion. Loss-of-function mutations in CFTR cause the genetic disease cystic fibrosis. CFTR is required for transepithelial fluid transport in certain secretor...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990321

    authors: Verkman AS,Synder D,Tradtrantip L,Thiagarajah JR,Anderson MO

    更新日期:2013-01-01 00:00:00

  • Delta opioid peptides derived from plant proteins.

    abstract::Opioid peptides showing selectivity for delta receptor have been isolated from enzymatic digests of plant proteins. Five peptides were derived from wheat gluten, and named gluten exorphins A5, A4, B5, B4 and C. Two opioid peptides were also released from spinach ribulose-bisphosphate-carboxylase/oxygenase (Rubisco), a...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033454838

    authors: Yoshikawa M,Takahashi M,Yang S

    更新日期:2003-01-01 00:00:00

  • Therapeutic effects of micronutrient supplements on sperm parameters: Fact or Fiction?

    abstract:BACKGROUND:Despite the limited evidence about the effect of micronutrient supplementation on the semen quality, many micronutrient supplements have been used to improve male fertility. Approximately, 40%-50% of male infertility cases in general and up to 80% in men with idiopathic infertility cases are caused by oxidat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200415173537

    authors: Dimitriadis F,Tsounapi P,Zachariou A,Kaltsas A,Sokolakis I,Hatzichristodoulou G,Symeonidis EN,Kotsiris D,Gabales MR,Vlachopoulou E,Takenaka A,Sofikitis N

    更新日期:2020-04-15 00:00:00

  • 3D Printing in Pharmaceuticals: Regulatory Perspective.

    abstract:BACKGROUND:The last few decades have witnessed enormous advancements in the field of Pharmaceutical drug, design and delivery. One of the recent developments is the advent of 3DP technology. It has earlier been successfully employed in fields like aerospace, architecture, tissue engineering, biomedical research, medica...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666181130163027

    authors: Mirza MA,Iqbal Z

    更新日期:2018-01-01 00:00:00

  • Ligand-Based Virtual Screening Using Tailored Ensembles: A Prioritization Tool for Dual A2AAdenosine Receptor Antagonists / Monoamine Oxidase B Inhibitors.

    abstract:BACKGROUND:Virtual Screening methodologies have emerged as efficient alternatives for the discovery of new drug candidates. At the same time, ensemble methods are nowadays frequently used to overcome the limitations of employing a single model in ligand-based drug design. However, many applications of ensemble methods ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160302103542

    authors: Helguera AM,Perez-Castillo Y,D S Cordeiro MN,Tejera E,Paz-Y-Miño C,Sánchez-Rodríguez A,Teijeira M,Ancede-Gallardo E,Cagide F,Borges F,Cruz-Monteagudo M

    更新日期:2016-01-01 00:00:00

  • KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin.

    abstract::Integrins alpha(1)beta(1) and alpha(2)beta(1) are highly expressed on the microvascular endothelial cells, and blocking of their adhesive properties significantly reduced the VEGF-driven neovascularization ratio and tumor growth in animal models. Hence, inhibitors of the alpha(1)beta(1) and alpha(2) beta(1) integrins,...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207782023766

    authors: Calvete JJ,Marcinkiewicz C,Sanz L

    更新日期:2007-01-01 00:00:00

  • Gold Nanomaterials: From Preparation to Pharmaceutical Design and Application.

    abstract::The present mini review offers a brief overview on the preparation and modification of gold nanomaterials (AuNMs) designed for biomedical applications, including biosensors, bioimaging, phototherapy and importantly gene/drug delivery. As biocompatibility is a prerequisite for safe pharmaceutical application, the poten...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666151210123225

    authors: Rossi M,Pina CD,Falletta E

    更新日期:2016-01-01 00:00:00

  • Modified polysaccharides as versatile materials in controlled delivery of antidegenerative agents.

    abstract::The mechanisms and factors causing or influencing degenerative diseases require tailor-made solutions. Natural polysaccharides are among the most versatile building units of the novel drug delivery systems. Their properties can be easily tailored to specific needs because they depend not only on the first-order struct...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212800492831

    authors: Karewicz A,Bielska D,Nowakowska M

    更新日期:2012-01-01 00:00:00

  • Epigenetic modification in neuropathic pain.

    abstract::Neuropathic pain is characterized by complicated combination of positive (e.g., hyperalgesia and allodynia) and negative (e.g., hypoesthesia and hypoalgesia) symptoms, and is often refractory to conventional pharmacological agents, including morphine. Although the molecular mechanisms for positive symptoms are extensi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666141027113923

    authors: Ueda H,Uchida H

    更新日期:2015-01-01 00:00:00

  • Beneficial effects of the Mediterranean diet on metabolic syndrome.

    abstract::The metabolic syndrome (MetS) represents a cluster of medical disorders, such as hyperglycemia, dyslipidemia, hypertension, and abdominal obesity that, when occurring together, increase the risk of developing cardiovascular disease. The role of food and nutrients in the aetiology of chronic diseases has become clearer...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612819666131206112144

    authors: Grosso G,Mistretta A,Marventano S,Purrello A,Vitaglione P,Calabrese G,Drago F,Galvano F

    更新日期:2014-01-01 00:00:00

  • Physiology and therapeutic potential of the thymic peptide thymulin.

    abstract::Thymulin is a thymic hormone exclusively produced by the epithelial cells of the thymus. After its discovery and initial characterization in the '70s, it was demonstrated that the production and secretion of thymulin are strongly influenced by the neuro-endocrine system. Conversely, a growing body of evidence, to be r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140130211157

    authors: Reggiani PC,Schwerdt JI,Console GM,Roggero EA,Dardenne M,Goya RG

    更新日期:2014-01-01 00:00:00

  • The influence of natural substrates and inhibitors on the nucleotide-dependent excision activity of HIV-1 reverse transcriptase in the infected cell.

    abstract::Human immunodeficiency virus type 1 resistance to nucleoside reverse transcriptase inhibitors such as 3'-azido-2', 3'-dideoxythymidine (AZT) can arise through mutations in the coding region of reverse transcriptase (RT) that enhance the enzyme's ability to remove the drug after it has been incorporated. This excision ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776873572

    authors: Smith AJ,Scott WA

    更新日期:2006-01-01 00:00:00

  • Up-date on diagnostic strategies of invasive aspergillosis.

    abstract::Invasive fungal infections are a major cause of morbidity and mortality in immunosuppressed patients with fatality rates ranging from 30 % to 80 % in neutropenic patients. This results at least partly in difficulties obtaining a reliable and early diagnosis, followed by the fact that clinical symptoms are unspecific a...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990323

    authors: Lackner M,Lass-Flörl C

    更新日期:2013-01-01 00:00:00

  • Metabolic targets of cardiac hormones' therapeutic anti-cancer effects.

    abstract::The heart is a sophisticated endocrine gland synthesizing a family of peptide hormones by three different genes. These cardiac hormones are stored as 3 prohormones, i.e. atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) prohormones. Within the ANP prohormones are 4 ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210790963887

    authors: Vesely DL

    更新日期:2010-01-01 00:00:00

  • 3D-QSAR studies on a series of inhibitors docked into a new homology model of the DNA-PK receptor.

    abstract::Cancer therapies through ionizing radiation or chemotherapeutic treatment may result in DNA double strand breaks (DSBs) in cell. DNA-PK has emerged as an attractive target for drug discovery efforts toward DSBs repair and in V(D)J recombination. Hence, the search for potent and selective DNA-PK inhibitors has received...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161209789649484

    authors: Cao R,Zeng H,Zhang H

    更新日期:2009-01-01 00:00:00

  • Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.

    abstract::In the third millennium preventive medicine is becoming a corner stone in our concept of health. Colorectal cancer (CRC) fits the criteria of a disease suitable for prevention interventions. It is a prevalent disease that is associated with considerable mortality and morbidity rates, with more than 1,000,000 new cases...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207781368783

    authors: Boursi B,Arber N

    更新日期:2007-01-01 00:00:00

  • Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues.

    abstract::Many plant species and tissues have been investigated as production and delivery vehicles for recombinant pharmaceutical proteins. Examples include cultured cells, whole aquatic plants and transgenic plants expressing recombinant proteins in their leaves, seeds, fruits or tubers/roots. Each platform has unique propert...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319310005

    authors: Hofbauer A,Stoger E

    更新日期:2013-01-01 00:00:00

  • Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections.

    abstract::Heme oxygenase-1 (HO-1) catalyzes the degradation of heme to generate carbon monoxide, biliverdin and free iron. Increased HO-1 levels constitute an anatomopathological feature of many neurological diseases, such as neurodegenerative disorders and brain infections, which correlate with exacerbated oxidative stress and...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208783597407

    authors: Cuadrado A,Rojo AI

    更新日期:2008-01-01 00:00:00

  • PET imaging in clinical drug abuse research.

    abstract::Over the last two decades, SPECT (single photon emission computed tomography) and especially PET (positron emission tomography) have proven increasingly effective imaging modalities in the study of human psychopharmacology. Abusing populations can be studied at multiple times after abstinence begins, to give informati...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774424717

    authors: Gatley SJ,Volkow ND,Wang GJ,Fowler JS,Logan J,Ding YS,Gerasimov M

    更新日期:2005-01-01 00:00:00

  • Alternative use of bisphosphonate therapy for rheumatic disease.

    abstract::Bisphosphonates are widely use for pathologies such as osteoporosis, Paget's disease or bone metastasis. However, their potent antiresorptive properties open new therapeutic opportunities for other conditions associated with an increased focal or systemic bone remodelling. Moreover, apart from their antiresorptive act...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210793563626

    authors: Le Goff B,Berthelot JM,Maugars Y,Romas E

    更新日期:2010-01-01 00:00:00

  • Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review.

    abstract::Chemotherapy is one of the most frequently employed and reliable treatment options for the management of a variety of cancers. Taxanes (paclitaxel, docetaxel and cabazitaxel) are frequently prescribed to treat breast cancer, hormone refractory prostate cancer, non-small cell lung cancer and ovarian cancer. Most of the...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160524144926

    authors: Kumar P,Raza K,Kaushik L,Malik R,Arora S,Katare OP

    更新日期:2016-01-01 00:00:00

  • Essential Oil and Ethanol Extract of Oregano (Origanum vulgare L.) from Armenian Flora as a Natural Source of Terpenes, Flavonoids and other Phytochemicals with Antiradical, Antioxidant, Metal Chelating, Tyrosinase Inhibitory and Antibacterial Activity.

    abstract:BACKGROUND:Origanum vulgare is used in Armenian cuisine as well as in folk medicine. The aim of this investigation was to determine the peculiarities of the chemical composition of Armenian flora's oregano essential oil (EO) and ethanol extract (EE) and to characterize mainly antioxidant and antibacterial properties in...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612825666190702095612

    authors: Moghrovyan A,Sahakyan N,Babayan A,Chichoyan N,Petrosyan M,Trchounian A

    更新日期:2019-01-01 00:00:00

  • Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.

    abstract::Humans have always lived with tubercle bacilli. Host susceptibility both inherited and acquired determines whether an individual infected with Mycobacterium tuberculosis will eventually fall ill and develop tuberculosis (TB). After infection with M. tuberculosis, a latent TB infection may ensue reflected by immune r...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211797470228

    authors: van Altena R,Duggirala S,Gröschel MI,van der Werf TS

    更新日期:2011-01-01 00:00:00

  • Hydrogen Gas as an Exotic Performance-Enhancing Agent: Challenges and Opportunities.

    abstract:BACKGROUND:Hydrogen gas (H2 ) has entered the world of experimental therapeutics approximately four and a half decades ago. Over the years, this simple molecule appears to drive more and more scientific attention perhaps due to a dualism of H2 affirmative features demonstrated in numerous in vitro, animal and human stu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200922155242

    authors: Ostojic SM

    更新日期:2020-09-22 00:00:00

  • Machine learning methods in prediction of protein palmitoylation sites: A brief review.

    abstract::Protein palmitoylation is a fundamental and reversible post-translational lipid modification that involves a series of biological processes. Although a large number of experimental studies have explored the molecular mechanism behind the palmitoylation process, the computational methods has attracted much attention fo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666201112142826

    authors: Li Y,Pu F,Wang J,Zhou Z,Zhang C,He F,Ma Z,Zhang J

    更新日期:2020-11-12 00:00:00

  • Role of nitric oxide in the central interferon-alpha-induced inhibition of gastric acid secretion in rats.

    abstract::Cytokines are known to play a key role in regulation of gastric functions. Interferon-alpha (IFN-α) has been published to impair gastric motility. Aims of this study were to clarify effect of IFN-α on gastric acid secretion (GAS) and determine role of nitric oxide (NO) in the process. Both subcutaneous (1000, 10000, 1...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128130104

    authors: Czimmer J,Király Á,Szabó IL,Mózsik G,Sütő G

    更新日期:2013-01-01 00:00:00

  • Telomerase modulation in therapeutic approach.

    abstract::Telomerase is a specialized enzymatic complex responsible for the synthesis of telomeric repeats 5'-TTAGGG-3' localized at the ends of eukaryotic chromosomes. This mechanism prevents shortening of telomeres after each cell division. The enzyme is detected in about 85% of human tumors, but it is not expressed in normal...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140630092721

    authors: Romaniuk A,Kopczynski P,Ksiazek K,Rubis B

    更新日期:2014-01-01 00:00:00

  • Benefits and Limitations of Polymorphic and Amorphous Forms of Active Pharmaceutical Ingredients.

    abstract::Active pharmaceutical ingredients (APIs) can exist in different polymorphic forms as well as in amorphous state. Polymorphic and amorphous forms of APIs can differ in physicochemical properties which in turn can significantly influence their therapeutic safety and effectiveness of the treatment. This review focuses on...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160804100036

    authors: Talaczynska A,Dzitko J,Cielecka-Piontek J

    更新日期:2016-01-01 00:00:00

  • Exploiting substrate recognition for selective inhibition of protein kinases.

    abstract::Protein kinases are potential targets of drugs to treat many human diseases. Intensive efforts have been made to develop protein kinase inhibitors, but a major challenge is achieving specificity. Exploiting regulatory elements outside the ATP binding pocket, such as the substrate binding site, may provide an alternati...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212800672741

    authors: Licht-Murava A,Eldar-Finkelman H

    更新日期:2012-01-01 00:00:00